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Abstract: Endophytes are microorganisms that are perceived as non-pathogenic symbionts found
inside plants since they cause no symptoms of disease on the host plant. Soil conditions and
geography among other factors contribute to the type(s) of endophytes isolated from plants.
Our research interest is the antibacterial activity of secondary metabolite crude extracts from
the medicinal plant Solanum mauritianum and its bacterial endophytes. Fresh, healthy stems of
S. mauritianum were collected, washed, surface sterilized, macerated in PBS, inoculated in the nutrient
agar plates, and incubated for 5 days at 30 ◦C. Amplification and sequencing of the 16S rRNA
gene was applied to identify the isolated bacterial endophytes. These endophytes were then grown
in nutrient broth for 7–14 days, after which sterilized Amberlite® XAD7HP 20–60 mesh (Merck
KGaA, Darmstadt, Germany) resin was added to each culture to adsorb the secondary metabolites,
which were later extracted using ethyl acetate. Concentrated crude extracts from each bacterial
endophyte were tested for antibacterial activity against 11 pathogenic bacteria and two human cancer
cell lines. In this study, a total of three bacterial endophytes of the Pantoea genus were identified from
the stem of S. mauritianum. The antibacterial test showed that crude secondary metabolites of the
endophytes and stem of S. mauritianum possessed antibacterial properties against pathogenic microbes
such as Escherichia coli, Staphylococcus aureus, Klebsiella pneumoniae, and Pseudomonas aeruginosa,
with concentrations showing inhibition ranging from 0.0625 to 8.0000 mg/mL. The anticancer analysis
showed an increase in cell proliferation when A549 lung carcinoma and UMG87 glioblastoma cell
lines were treated with both the plant and endophytes’ crude extracts. As far as we know, this is the
first study of its kind on Solanum mauritianum in South Africa showing S. mauritianum endophytes
having activity against some of the common human pathogenic organisms.
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1. Introduction
Infectious diseases caused by bacteria, fungi, viruses, and parasites are major public health
concerns, despite the remarkable progress in human medicine. Their impact is exceptionally great in
developing countries due to the relative unavailability of effective medicines and the rise of widespread
drug resistance [1,2]. The emergence and spread of antimicrobial resistant pathogens is progressively
increasing, making the current available antimicrobials less effective and in need of reviewing. In recent
years, there has been a growing awareness and interest in the study of medicinal plants and their
endophytes as alternative sources for bioactive compounds against resistant microorganisms [3,4].
Endophytes are microorganisms that live or spend a part of their life cycle in the internal tissues
of the plants without causing any symptoms of disease in the plant [5–12]. In certain instances,
endophytes can mimic the chemistry of their respective host plants to produce similar bioactive
natural products, or derivatives that are more bioactive than those of their hosts [13,14]. An example
can be seen with the case of taxol being produced by a series of endophytes from yews as well as
other plant sources [15,16]. Endophytes which produce the same important bioactive compounds
such as peptides, steroids, phenolic compounds, aliphatic compounds, terpenoids, alkaloids, lignans,
and isocoumarins [12], as their host plants not only reduce the need to harvest slow growing and
possibly rare plants, but also preserve the world’s ever diminishing biodiversity. Additionally, it is
recognized that a microbial source of a valued product may be easier and more economical to produce,
effectively reducing its market price [3]. Kakadumycin A, isolated from a Streptomyces species found in
the plant Grevillea pteridofolia, Camptothecin from Paenibacillus polymyxa found in Camptotheca acuminate,
and Asparaginase from Pseudomonas oryzihabitans, isolated from Hibiscus rosasinensis, are some bioactive
compounds extracted from endophytes [12].
Our interest in this study was on the medicinal plant Solanum mauritianum, its bacterial
endophytes, and the antibacterial activities of secondary metabolite crude extracts of the two. As far
as we know, S. mauritianum is a plant which has been underexplored with regards to its endophytes.
S. mauritianum is an invasive weedy plant species from the family Solanaceae, which has been reported
to be useful in South African traditional medicine for the treatment of menorrhagia [17,18], dysentery,
diarrhoea [18,19], and infertility [18,20]. The main aim of this study was to determine the bacterial
endophyte diversity of S. mauritianum and the antibacterial activity of both the plant and endophytes’
secondary metabolite crude extracts on selected pathogenic bacteria.
2. Materials and Methods
2.1. Sample Collection
Fresh, healthy (showing no apparent symptom of disease) stems of S. mauritinum plant were
collected from the University of Johannesburg, Doornfontein Campus, located in Johannesburg,
South Africa. The samples were transported to the laboratory where the plant was thoroughly washed
with sterile distilled water and used within four hours.
2.2. Endophytes Isolation and Identification
The stems were surface-sterilized separately, using the method described by [12,21]. Briefly,
each sample (approximately 10 g) was treated with 5% Tween 20 (enough to cover the plant material)
and shaken vigorously for five minutes. The Tween 20 was removed by rinsing several times with sterile
distilled water. The sample was then disinfected with 70% ethanol for one minute. Traces of the ethanol
were removed by rinsing with sterile distilled water five times. The sample was then treated with
1% Sodium Hypochlorite (NaHClO) for ten minutes and rinsed five times with sterile distilled water.
The last rinse was used as a control and 100 µL of it was plated on Nutrient Agar (NA). The sample
was then macerated in sterilized phosphate-buffered saline (PBS) with the outer surface trimmed out.
The macerated sample was serially diluted up to 10−3 dilution and each dilution inoculated (using
spread plate method) in triplicates on and Nutrient Agar (NA) (for bacteria enumeration). The NA
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plates were incubated at 30 ◦C, (IncoTherm, Labotec, Johannesburg, South Africa). The growth was
monitored periodically for 5 days during the incubation period. Effectiveness of the sterilization
was monitored on the wash control plate, with growth indicating poor sterilization. Under such
circumstances, the plates were discarded, and the sterilization repeated.
Distinct colonies were selected and sub-cultured on the appropriate NA to obtain pure isolates.
Pure bacterial isolates were preserved in 50% glycerol on a ratio of 1 mL glycerol to 1 mL overnight
broth culture and stored at −80 ◦C.
2.2.1. Morphological Identification of Bacterial Endophytes
Gram stain technique as described by [22] was done to determine cell morphology.
2.2.2. Molecular Identification
Genomic DNA Extraction, Polymerase Chain Reaction, and Sequencing
Genomic DNA of each bacterial endophyte isolate was extracted from pure colonies obtained from
nutrient agar plates. The DNA was extracted using Bacterial DNA kit (Zymo Research, catalog NO
R2014). The extracted DNA was quantified using the NanoDrop ND-2000 UV-Vis spectrophotometer
(Thermo Fisher scientific, Waltham, MA, USA). The 16S rRNA gene of each bacterial isolate was
amplified by PCR following [23]. Briefly, the 16S rRNA gene was amplified using the primers
(16S-27F: 5′-AGAGTTTGATCMTGGCTCAG-3′ and 16S-1492R: 5′-CGGTTACCTTGTTACGACTT-3′)
with 2x PCR master mix with standard buffer. The PCR products were cleaned with ExoSAP-it™
following manufacturers’ recommendations and sequencing was done at Inqaba Biotechnical Industries
(Pty) Ltd., Pretoria, South Africa.
Phylogenetic Analysis
The obtained sequences were screened for chimeras using DECIPHER23 and subjected to
BLAST analysis at the National Center for Biotechnology Information (NCBI) against the prokaryotic
rRNA sequence database (Bacteria and archaea) to identify the closest bacterial species. Bacterial
species with 98–100% similarity were selected for phylogenetic analysis. Alignments of nucleotide
sequences (isolate and species obtained through BLAST) were performed using MUSCLE with default
options. Phylogenetic trees were constructed using the neighbour-joining (NJ) method based on
the Tamura–Nei model. A total of 1000 replications were used for the bootstrap test. All branches
with a bootstrap value greater than 50% were considered to be significant. The positions containing
gaps and missing nucleotide data were eliminated. All evolutionary analyses were conducted in
MEGA 7.27. The 16S rRNA gene sequences of bacterial isolates identified in the study were deposited
in GenBank (www.ncbi.nlm.nih.gov/genbank/) with the accession numbers as stated in Table 1.
The assigned names of the bacterial isolates were based on the BLAST homology percentages as well
as phylogenetic results.
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2.3. Biological Activity Assay
2.3.1. Isolation of Secondary Metabolites from Endophytes
Secondary metabolites were extracted from the endophytic bacteria using the method described
earlier [24] with modifications. The endophytic bacteria isolated from S. mauritianum were cultured
in three 5 L Schott bottles each containing 3 L of a nutrient broth and shaken at 200 rpm at 27 ◦C
for seven days. After seven days of cultivation, sterilized Amberlite® XAD7HP 20–60 mesh (Merck
KGaA, Darmstadt, Germany) resin (60 g/L) (Sigma–Aldrich, Johannesburg, South Africa) was added
to adsorb the organic products, and the culture and resin were shaken at 200 rpm for 2 h. The resin
was filtered through cheesecloth and washed three times with 250 mL of acetone for each wash.
The acetone soluble fraction was concentrated using a rotary evaporator and a dark brown viscous
extract was obtained.
The extract was transferred into a measuring cylinder and based on the volume, ethyl acetate was
added in a 1:1 ratio (v/v). The mixture was shaken vigorously for 5–10 min, poured into a separating
funnel and allowed to separate; this was done until the dark brown viscous liquid obtained after
removing the acetone became a light-yellow liquid. The ethyl acetate fraction was removed using
a rotary evaporator and the extract was stored in an amber bottle in a cool dry place until analysis was
done. The light-yellow liquid was evaporated (to ensure there was no extract lost) leaving behind no
reasonable extract. No further analysis was done on this.
2.3.2. Extraction of the Solanum Mauritianum Plant Part
The method described by [25,26] with slight adjustments was used for the preparation of the
crude extracts of the stems of S. mauritianum. The dried plant part was blended into a fine powder
with a shop-bought coffee mill and 200 g of plant powder was weighed into a Schott bottle, 2000 mL
of a methanol/chloroform (50:50, v/v) solution was added and the Schott bottle left on a platform
shaker for three days. The extract suspension was filtered through Whatman No. 1 filter paper
and evaporated to dry out the solvent, using a rotatory evaporator with consideration to the boiling
points of the extracting solvents. The process was repeated another two times to ensure maximal
extraction of compounds. The crude extract was collected in a beaker and placed in a desiccator to dry
out completely.
2.3.3. Determination of Anti-Bacterial Activity
The Minimum Inhibitory Concentrations (MIC) method was used in this study to determine the
antibacterial activity of crude extracts from the plant and bacterial endophytes. The following bacterial strains
were used: Bacillus cereus (ATCC10876), Bacillus subtilis (ATCC19659), Enterobacter aerogenes (ATTC13048),
Escherichia coli (ATCC10536), Klebsiella pneumonia (ATCC10031), Mycobacterium smegmatis (ATCC21293),
Mycobacterium marinum (ATCC927), Proteus vulgaris (ATCC 33420), Pseudomonas aeruginosa (ATCC10145),
Staphylococcus aureus (ATCC25923), Streptococcus epidermidis (ATCC14990).
MICs were carried out according to the method outlined by [26] and [27]. The bacterial strains
were inoculated into Mueller Hinton (MH) broth and allowed to grow overnight in an incubator at
37 ◦C for 24 to 36 h, depending on the growth rate of each bacteria, and compared to a 0.5 McFarland’s
standard. The antibiotic, Streptomycin, was used as the positive control and was prepared by weighing
0.032 mg in 1 mL of sterile distilled water while DMSO was used as a negative control.
The crude secondary metabolite extracts from the identified endophytes were weighed (0.176 g)
into empty autoclaved MacCourtney bottles to ensure sterility. The crude extracts were dissolved
in DMSO (0.1%) to make a stock solution of 32 mg/mL. Serial dilutions were carried out using the
MH broth from 16 mg/mL down to 0.03125 mg/mL. The outer wells of the plate were filled with
sterile distilled water. Standardized overnight bacterial cultures (100 µL) were added into each well
horizontally and vertically in 5 repeats for each bacterium. In vertical order, 100 µL of the diluted
samples were added in the wells from 16 mg/mL down to 0.03125 mg/mL. The plates were covered
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and incubated overnight at 37 ◦C. Resazurin sodium salt solution (10 µL of 0.02% (w/v)) was added
to the wells and incubated for another two hours. Upon reduction, resazurin changes colour from
blue to pink to clear, as oxygen becomes limited within the medium, indicating metabolism. The well
with a known concentration showing a slight colour change was used as MIC. The wells were visually
inspected for colour changes.
2.3.4. Anticancer Assays
Crude extracts of S. mauritianum stems and secondary metabolites derived from bacterial
endophytes were tested against two ATCC cancer cell lines: U87MG Glioblastoma and A549 Lung
carcinoma cells for anticancer activity. The crude samples were weighed in Eppendorf tubes, 0.1%
DMSO was added and sonicated to aid dissolution, and a stock solution of 200 µg/mL was made.
Serial dilutions were carried out using growth media from 100 µg/mL to 3.13 µg/mL. An MTS
(3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxy-phenyl)-2-(4-sulfophenyl)-2H-tetrazolium) in vitro
cytotoxicity assay was conducted to determine change in cell viability, through a colour change.
An MTS compound (yellow) is metabolized by viable cells to form a dark purple-coloured compound,
visible through UV Vis spectroscopy at 490 nm. The absorbance is directly proportional to the cell
viability. The samples were analyzed in duplicates across three plates (n = 6) and the average value
reported. The U87MG cells and A549 cells were grown using normal tissue culture techniques and 15%
FBS addition. The cells (1× 105 cells/mL) were incubated in 96 well plates at 37 ◦C overnight, with the
subsequent addition of the supplied compounds, in concentrations of (100 µg/mL, 50.0 µg/mL,
25.0 µg/mL, 12.5 µg/mL, 6.25 µg/mL, 3.125 µg/mL, and 0 µg/mL). The cells were left to incubate
for 4 days, after which MTS (5 µL) was added to the cells. The absorbance values were measured
at 490 nm after 1 h, 2 h, and 4 h incubation periods, averaged and the viability curves drawn up.
Auranofin was used as a positive control [28], based on its excellent activities against non-small cell
lung cancer cells [29,30].
3. Results
3.1. Identification of Bacterial Endophytes
In this study, three bacterial endophytes (from the Enterobacteriaceae family) of the Pantoea genus
isolated and identified from the stem of S. mauritianum are shown in Table 1.
The accession numbers of the isolated endophytes are also shown in Table 1. All isolates had 99%
similarities with other strains obtained from GenBank. The results of the effectiveness of the surface
sterilization method showed no microbial growth in the control plates, indicating that the isolates were
endophytes (Gram negative rods). Relationships between the three Pantoea genus endophytic bacteria
isolated from the S. mauritianum stem and other species of the same families are shown in Figure 1.
The phylogenetic analysis showed that the endophytic bacterial isolates aligned with various closely
related bacterial species.
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Figure 1. Neighbour-joining tree based on 16S rRNA gene sequence of three endophytic bacteria,
isolated from S. mauritianum and other similar species selected from GenBank.
3.2. Antibacterial Activity of Bacterial Endophytes and Plant Part
Minimum inhibitory concentration of extracted secondary metabolites ranged from 8.000 mg/mL
to 0.0625 mg/mL. Several samples showed inhibition at a concentration of 0.125 mg/mL,
showing potential for development into compounds with promising bioactivities against pathogenic
microorganisms, as seen in Table 2.
Table 2. Minimum Inhibitory Concentration (MIC) values of the antibacterial activity test carried out
















B. cereus Positive 0.5000 0.1250 0.5000 0.1250 0.03125
B. subtilis Positive 0.1250 0.2500 0.5000 0.1250 0.03125
E. aerogenes Negative 8.0000 4.0000 4.0000 2.0000 0.12500
E. coli Negative 1.0000 0.5000 0.5000 0.5000 0.12500
K. pneumoniae Negative 8.0000 2.0000 4.0000 0.5000 0.12500
M. marinum Positive 0.5000 0.1250 0.5000 0.5000 0.06250
M. smegmatis Positive 0.1250 0.1250 0.1250 0.1250 0.06250
P. vulgaris Negative 4.0000 0.5000 4.0000 0.5000 0.12500
P. aeruginosa Negative 4.0000 1.0000 2.0000 0.1250 0.12500
S. aureus Positive 0.1250 0.0625 0.1250 0.0625 0.03125
S. epidermidis Positive 0.5000 0.1250 0.1250 0.1250 0.06250
3.3. Effects of Bacterial Endophytes and Plant Parts on Cancer Cells
The extracts showed no notable anticancer activity against the glioblastoma and lung carcinoma
cells as observed in Figures 2 and 3. An increase in cell viability was observed at the highest
concentrations, which is 100 µg/mL for each of the analyzed extracts.
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Figure 2. Cytotoxic effects of crude secondary metabolites from the stem of S. mauritianum and
its bacterial endophytes on A549 Lung carcinoma cells tested at different concentrations, ranging
from 100–3.13 µg/mL. Auranofin was used as positive control. N1 = P. ananatis, N3 = P. eucalypti,
N5 = P. vagans, and N18 = S. mauritianum stem.
Figure 3. Cytotoxic effects of crude secondary metabolites from the stem of S. mauritianum and
its bacterial endophytes on UMG87 glioblastoma cells tested at different concentrations ranging
from 100–3.13 µg/mL. Auranofin was used as positive control. N1 = P. ananatis, N3 = P. eucalypti,
N5 = P. vagans, and N18 = S. mauritianum stem.
4. Discussion
Endophytes are known to vary in diversity based on seasonal collection or sampling time, plant
age, plant tissue type, and environment [21]. Recent studies have equally documented Pseudomonas,
Bacillus, Pantoea and Enterobacter as bacterial endophytes in plants [31–33].
The assignment of bacterial isolates to a given species requires further phenotypic and molecular
characterization. Based on this study, the isolates had 99% similarity to Pantoea vagans strain UFLA
WCF767, Pantoea agglomerans strain FC2948, Pantoea ananatis strain P5, and Pantoea eucalypti strains
EV2 and EV4. There are reports showing the association of Pantoea species with plants [34]. However,
Pantoea agglomerans has been shown to act as a biocontrol agent on cotton [35], produce antibiotics that
inhibit Erwinia amylovora [36], and promote plant growth [37,38].
Metabolites bearing antibiotic activity can be defined as low-molecular-weight organic natural
substances, which are characterized by a molecular weight below 900 Dalton, made by microorganisms
that are active at low concentrations against other microorganisms [13]. For example, Gentamicin,
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which is produced by the fermentation of Micromonospora purpurea, is known to be active at
concentration 0.25 mg/L against E. coli [39]. Endophytes are believed to carry out a resistance
mechanism to overcome pathogenic invasion by producing secondary metabolites [40]. P. ananatis
extracts, when compared to other endophytes in this study, had the most significant MIC values
between 0.0625 and 4.000 mg/mL. The most significant MIC value of 0.0625 mg/mL was seen on
pathogenic Staphylococcus aureus. Other notable inhibitory activities were seen on B. cereus, M. marinum,
M. smegmatis, and S. epidermidis with a MIC value of 0.125 mg/mL and B. subtilis with a MIC of
0.250 mg/mL. Antimicrobial activity of a bioactive compound from P. ananatis has been reported in
a previous study by [41], which could support the notable inhibitory activity of its crude secondary
metabolites in this study.
P. vagans extracts had MIC values ranging from 0.125 to 8.000 mg/mL. The most susceptible
microbes were B. subtilis, M. smegmatis, and S. aureus, with a MIC value of 0.125 mg/mL. A notable
MIC value of 0.500 mg/mL was also observed for B. cereus and S. epidermidis. A peptide present in
P. vagans has been reported to possess antibacterial activity [42] and this could serve as a justification
for the antibacterial activity seen in the crude secondary metabolite extracts of P. vagans.
P. eucalypti extracts showed MIC values between 0.125 and 4.000 mg/mL. Noteworthy inhibition
was observed for M. smegmatis, S. aureus and S. epidermidis, with a MIC value of 0.125 mg/mL. Other
significant inhibitions were seen on B. cereus, B. subtilis, E. coli, and M. marinum, with a MIC value of
0.500 mg/mL. This, to the best of our knowledge, is an initial report on the antibacterial activity of
secondary metabolites from P. eucalypti.
The stem of S. mauritianum which was the host of the isolated endophytes was also analyzed
for antibacterial activity. The MIC values seen for the stem crude extracts ranged from 0.0625 to
2.000 mg/mL. The crude extract showed very significant activity against S. aureus with a MIC
value of 0.0625 mg/mL, which is also the same MIC seen on S. aureus when P. ananatis secondary
metabolites were tested against it. There was activity seen for B. cereus, B. subtilis, M. smegmatis,
P. aeruginosa and S. epidermidis, with MICs of 0.125 mg/mL. A MIC of 0.500 mg/mL was seen for E. coli,
K. pneumonia, M. marinum, and P. vulgaris. Several Solanum species have been previously reported
to have antibacterial activities against S. aureus, E. coli, P. aeruginosa, B. subtilis, and other common
bacterial pathogens [43–47]. These reports validate the results on the antibacterial activity of the stem
of S. mauritianum reported in this study.
Crude extracts exhibiting activity at concentration 1 mg/mL or lower are considered active [48].
In this study, crude secondary metabolites from both the plant part and isolated endophytes showed
notable antibacterial activities against pathogenic microbes. Antimicrobial activity of compounds
produced by plant endophytes have previously been reported [49,50]. It has also been reported that
endophytes are the chemical synthesizers within plants. Many of them are capable of synthesizing
bioactive compounds that can be used by plants for defense against pathogens and some of these
compounds have been reported to be useful for drug discovery [13,14]. This supports the inhibitory
activities seen in both the plant part analyzed and the isolated endophytes. It can also be seen from
the results that the Gram-positive bacteria were more susceptible to both plant and endophyte crude
extracts than the Gram-negative bacteria. This could be due to the presence of the outer membrane in
the Gram-negative organisms, which excludes certain drugs and antibiotics from penetrating the cell.
This in part accounts for why Gram-negative bacteria are generally more resistant to antibiotics than the
Gram-positive bacteria [51]. The results from this study suggest that the secondary metabolites from
the S. mauritianum plant and its bacterial endophytes could be explored further for the development of
new pharmaceutical products against pathogens.
Although it has been previously indicated that different plant parts in some other species of
Solanum possess anticancer properties (S. nigrum leaves possess anticancer properties against Ehrlich
ascites carcinoma cell (EACC) line and Hepatoma cell (HepG2) line [52], tomatidine and solasodine
from S. aculeastrum were shown to have an inhibitory effect on HT-29 (colonic adenocarcinoma),
HeLa (cervical carcinoma), and MCF-7 (breast adenocarcinoma) cells [53]), the stem crude extract
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of S. mauritianum showed no antiproliferative effect on both cancer cell lines used in this study.
To the best of our knowledge, there is no previous report on the anticancer properties of any
of the Pantoea endophytes reported in this study, although exopolysaccharides isolated from an
endophyte, Bacillus amyloliquefaciens, showed anticancer activity against gastric carcinoma cell lines [54].
Other studies on anticancer properties of fungal endophytes have also been previously reported
elsewhere [55–57]. The anticancer analysis of crude secondary metabolites from both endophytes
and the plant part in this study showed no notable anticancer activity against the two cancer cell
lines treated. It is reported that Glioblastoma (GB) and lung cancer are among the most lethal human
cancers. GB tumor cells as well as lung cancer cells have been shown to exhibit drug resistance and
are highly infiltrative [58–60]. This resistance could account for the results observed in this study.
Resistance to treatment and poor survival have been attributed to the presence of cancer stem cells
(CSCs) in GB [61,62] and in lung carcinoma cells [63].
5. Conclusions
Microbe–plant interactions are far from being fully understood. Nevertheless, more evidence
shows plant-associated microorganisms provide substantial benefits to agriculture, industry, and the
environment. In brief, this study determined the existence of a plant–microbe relationship in the stems
of S. mauritianum and the antimicrobial activity of the crude extracts of the plant and microbes,
which showed notable inhibitory activities. The antibacterial results show the potential use of
endophytic bacteria for the isolation of pure bioactive compounds and possible drug discovery.
Further research needs to be carried out to isolate and identify pure active compounds produced
by endophytes.
Author Contributions: N.U., T.S., K.T. contributed to the experimental work, L.M. provided materials used for
anticancer studies, E.G. provided materials used for antibacterial studies and co-supervised the project, V.M.
provided materials used for anticancer studies, designed, and supervised the project. All authors were involved
in the perusal of this manuscript.
Funding: This research was funded by the South African National Research Foundation (Thuthuka NRF Rating
Track: Grant TTK150713125714) and Department of Science and Technology through the Artificial Wetland
Research (AWARE) project.
Acknowledgments: The authors would like to acknowledge the Global Excellence Stature Scholarships, University
of Johannesburg merit bursary for postgraduate students for supporting this work.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. Okeke, I.N.; Laxminarayan, R.; Bhutta, Z.A.; Duse, A.G.; Jenkins, P.; O’Brien, T.F.; Pablos-Mendez, A.;
Klugman, K.P. Antimicrobial resistance in developing countries. Part I: Recent trends and current status.
Lancet Infect. Dis. 2005, 5, 481–493. [CrossRef]
2. Cos, P.; Vlietinck, A.J.; Berghe, V.D.; Maes, L. Anti-infective potential of natural products: How to develop
a stronger in vitro “proof-of-concept”. J. Ethnopharmacol. 2006, 106, 290–302. [CrossRef] [PubMed]
3. Strobel, G.; Daisy, B. Bioprospecting for microbial endophytes and their natural products. Microbiol. Mol. Biol. Rev.
2003, 67, 491–502. [CrossRef]
4. Strobel, G.A. Endophytes as sources of bioactive products. Microbes Infect. 2003, 5, 535–544. [CrossRef]
5. Wilson, D. ‘Endophyte: The Evolution of a Term, and Clarification of Its Use and Definition’. Oikos 1995, 73,
274–276. [CrossRef]
6. Azevedo, J.L.; Maccheroni, W., Jr.; Pereira, J.O.; de Araújo, W.L. Endophytic microorganisms: A review on
insect control and recent advances on tropical plants. Electron. J. Biotechnol. 2000, 3, 15–16. [CrossRef]
7. Stone, J.K.; Bacon, C.W.; White, J.F. An overview of endophytic microbes: Endophytism defined. In Microbial
Endophytes; Bacon, C.W., White, J.F., Eds.; Marcel Decker Inc.: New York, NY, USA 2000; p. 3030.
8. Saikkonen, K.; Wali, P.; Helander, M.; Faeth, S.H. Evolution of endophyte-plant symbiosis. Trends Plant Sci.
2004, 9, 275–280. [CrossRef] [PubMed]
Int. J. Environ. Res. Public Health 2019, 16, 602 10 of 12
9. Giménez, C.; Cabrera, R.; Reina, M.; González-Coloma, A. ‘Fungal Endophytes and their Role in Plant
Protection’. Curr. Org. Chem. 2007, 11, 707–720. [CrossRef]
10. Wani, Z.A.; Ashraf, N.; Mohiuddin, T.; Riyaz-Ul-Hassan, S. ‘Plant-endophyte symbiosis, an ecological
perspective’. Appl. Microbiol. Biotechnol. 2015, 99, 2955–2965. [CrossRef]
11. Gouda, S.; Das, G.; Sen, S.K.; Shin, H.S.; Patra, J.K. ‘Endophytes: A treasure house of bioactive compounds of
medicinal importance’. Front. Microbiol. 2016, 7, 1–8. [CrossRef]
12. Nchabeleng, E.K. Determination of biological activity of Celtis africana extracts and its endophytic microflora
and mycoflora. Masters Thesis, Department of Biotechnology and Food Technology, University of
Johannesburg, Johannesburg, South Africa, 2017.
13. Guo, B.; Wang, Y.; Sun, X.; Tang, K. Bioactive natural products from endophytes: A review. Appl. Biochem. Microbiol.
2008, 44, 136–142. [CrossRef]
14. Sadrati, N.; Daoud, H.; Zerroug, A.; Dahamna, S.; Bouharati, S. Screening of antimicrobial and antioxidant
secondary metabolites from endophytic fungi isolated from wheat (Triticum durum). J. Plant Prot. Res. 2013,
53, 128–136. [CrossRef]
15. Stierle, A.; Strobel, G.; Stierle, D. Taxol and taxane production by Taxomyces andreanae, an endophytic fungus
of Pacific yew. Science 1993, 260, 214–216. [CrossRef] [PubMed]
16. Owen, N.L.; Hundley, N. Endophytes the chemical synthesizers inside plants. Sci. Prog. 2004, 87, 79–99.
[CrossRef] [PubMed]
17. Jäger, A.K.; Hutchings, A.; Van Staden, J. ‘Screening of Zulu medicinal plants for prostaglandin-synthesis
inhibitors’. J. Ethnopharmacol. 1996, 52, 95–100. [CrossRef]
18. Lewu, F.B.; Afolayan, A.J. ‘Ethnomedicine in South Africa: The role of weedy species’. Afr. J. Biotechnol. 2009,
8, 929–934.
19. Watt, J.M.; Breyer-Brandwijk, M.G. The Medicinal and Poisonous Plants of Southern and Eastern Africa, 2nd ed.;
Livingstone: London, UK, 1962.
20. Mabogo, D.E.N. The Ethnobotany of the VhaVenda. Master’s Thesis, Department of Botany, University of Pretoria,
Pretoria, South Africa, 1990.
21. Jasim, B.; Joseph, A.A.; John, C.J.; Mathew, J.; Radhakrishnan, E.K. ‘Isolation and characterization of plant
growth promoting endophytic bacteria from the rhizome of Zingiber officinale’. 3 Biotech 2014 2014, 4,
197–204. [CrossRef] [PubMed]
22. Collins, M.D.; Falsen, E.; Brownlee, K.; Lawson, P.A. ‘Helcococcus sueciensis sp. nov., isolated from a human
wound’. Int. J. Syst. Evol. Microbiol. 2004, 54, 1557–1560. [CrossRef] [PubMed]
23. Yeates, C.; Gillings, M.R.; Davison, A.D.; Altavilla, N.; Veal, D.A. PCR amplification of crude microbial DNA
extracted from soil. Lett. Appl. Microbiol. 1997, 25, 303–307. [CrossRef] [PubMed]
24. Maloney, K.N.; MacMillan, J.B.; Kauffman, C.A.; Jensen, P.R.; DiPasquale, A.G.; Rheingold, A.L.; Fenical, W.
Lodopyridone, a structurally unprecedented alkaloid from a marine actinomycete. Org. Lett. 2009, 11,
5422–5424. [CrossRef]
25. Fomogne-Fodjo, M.C.Y.; Van Vuuren, S.; Ndinteh, D.T.; Krause, R.W.M.; Olivier, D.K. Antibacterial activities
of plants from Central Africa used traditionally by the Bakola pygmies for treating respiratory and
tuberculosis-related symptoms. J. Ethnopharmacol. 2014, 155, 123–131. [CrossRef] [PubMed]
26. Uche-Okereafor, N.C. Phytochemical screening, elemental analysis and antibacterial investigation of Rhoicissus
tomentosa: A medicinal plant used in South African traditional medicine. Masters. Thesis, Department of
Biotechnology and Food Technology, University of Johannesburg, Johannesburg, South Africa, 2016.
27. Andrews, J.M. Determination of minimum inhibitory concentrations. J. Antimicrob. Chemother. 2001, 48
(Suppl. 1), 5–16. [CrossRef] [PubMed]
28. McCauley, J.; Zivanovic, A.; Skropeta, D. Bioassays for anticancer activities. Methods Mol. Biol. 2013, 1055,
191–205. [PubMed]
29. Li, H.; Hu, J.; Wu, S.; Wang, L.; Cao, X.; Zhang, X.; Dai, B.; Cao, M.; Shao, R.; Zhang, R.; et al.
Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung
cancer cells. Oncotarget 2015, 7, 3548–3558. [CrossRef] [PubMed]
30. Roder, C.; Thomson, M.J. Auranofin: Repurposing an Old Drug for a Golden New Age. Drugs R&D 2015, 15,
13–20.
Int. J. Environ. Res. Public Health 2019, 16, 602 11 of 12
31. Dujiff, B.J.; Gianinazzi-Pearson, V.; Lemanceau, P. Involvement of the outer membrane lipopolysaccharides in
the endophytic colonization of tomato roots by biocontrol Pseudomonas fluorescens strain WCS417r. New Phytol.
1997, 135, 325–334. [CrossRef]
32. Hallmann, J.; Ha Umann, A.Q.; Mahaffee, W.F.; Kloepper, J.W. Bacterial endophytes in agricultural crops.
Can. J. Microbiol. 1997, 43, 895–914.
33. Akinsanya, M.A.; Goh, J.K.; Lim, S.P.; Ting, A.S.Y. Diversity, antimicrobial and antioxidant activities of
culturable bacterial endophyte communities in Aloe vera. FEMS Microbiol. Lett. 2015, 362, 184. [CrossRef]
34. Ferreira, A.; Quecine, M.C.; Lacava, P.T.; Oda, S.; Azevedo, J.L.; Araújo, W.L. Diversity of endophytic bacteria
from Eucalyptus species seeds and colonization of seedlings by Pantoea agglomerans. FEMS Microbiol. Lett.
2008, 287, 8–14. [CrossRef]
35. Medrano, E.G.; Bell, A.A. Role of Pantoea agglomerans in opportunistic bacterial seed and boll rot of cotton
(Gossypium hirsutum) grown in the field. J. Appl. Microbiol. 2007, 102, 134–143. [CrossRef]
36. Wright, S.A.I.; Zumoff, C.H.; Schneider, L.; Beer, S.V. Pantoea agglomerans strain EH318 produces two
antibiotics that inhibit Erwinia amylovora in vitro. Appl. Environ. Microbiol. 2001, 67, 284–292. [CrossRef]
[PubMed]
37. Procópio, R.E.L. Diversidade bacteriana endofítica de Eucalyptus spp. e avaliação do seu potencial
biotecnológico. Ph.D. Thesis, Universidade de São Paulo, São Paulo, Brazil, 2004.
38. Feng, Y.; Shen, D.; Song, W. Rice endophyte Pantoea agglomerans YS19 promotes host plant growth and affects
allocations of host photosynthates. J. Appl. Microbiol. 2006, 100, 938–945. [CrossRef] [PubMed]
39. Rodloff, A.; Bauer, T.; Ewig, S.; Kujath, P.; Müller, E. Susceptible, Intermediate, and Resistant—The Intensity
of Antibiotic Action. Dtsch. Arztebl. Int. 2008, 105, 657–662. [CrossRef] [PubMed]
40. Tan, R.X.; Zou, W.X. Endophytes: A rich source of functional metabolites. Nat. Prod. Rep. 2001, 18, 448–459.
[CrossRef] [PubMed]
41. Pomini, A.M.; Araújo, W.L.; Marsaioli, A.J. Structural Elucidation and Biological Activity of Acyl-homoserine
Lactones from the Phytopathogen Pantoea ananatis Serrano 1928. J. Chem. Ecol. 2006, 32, 1769–1778. [CrossRef]
[PubMed]
42. Kamber, T.; Lansdell, T.A.; Stockwell, V.O.; Ishimaru, C.A.; Smits, T.H.M.; Duffy, B. Characterization of the
biosynthetic operon for the antibacterial peptide herbicolin in Pantoea vagans biocontrol strain C9-1 and
incidence in Pantoea species. Appl. Environ. Microbiol. 2012, 78, 4412–4419. [CrossRef] [PubMed]
43. Chah, K.F.; Muko, K.N.; Oboegbulem, S.I. Antimicrobial activity of methanolic extract of Solanum torvum
fruit. Fitoterapia 2000, 71, 187–189. [CrossRef]
44. Aliero, A.A.; Afolayan, A.J. Antimicrobial activity of Solanum tomentosum. Afr. J. Biotechnol. 2006, 5, 369–372.
45. Koduru, S.; Grierson, D.S.; Afolayan, A.J. Antimicrobial Activity of Solanum aculeastrum. Pharm. Biol. 2006,
44, 283–286. [CrossRef]
46. Niño, J.; Correa, Y.M.; Mosquera, O.M. Antibacterial, Antifungal, and Cytotoxic Activities of 11 Solanaceae
Plants from Colombian Biodiversity. Pharm. Biol. 2006, 44, 14–18. [CrossRef]
47. Rana, S.; Prakash, V.; Sagar, A. Antibacterial Activity of Solanum xanthocarpum Leaf Extract. Int. J. Curr. Microbiol.
Appl. Sci. 2016, 5, 323–328. [CrossRef]
48. Van Vuuren, S.F. Antimicrobial activity of South African medicinal plants. J. Ethnopharmacol. 2008, 119,
462–472. [CrossRef] [PubMed]
49. Huang, Y.; Wang, J.; Li, G.; Zheng, Z.; Su, W. Antitumor and antifungal activities in endophytic fungi isolated
from pharmaceutical plants Taxus mairei, Cephalataxus fortunei and Torreya grandis. FEMS Immunol. Med. Microbiol.
2001, 31, 163–167. [CrossRef]
50. Li, J.Y.; Strobel, G.A. Jesterone and hydroxy-jesterone antioomycete cyclohexenenone epoxides from the
endophytic fungus Pestalotiopsis jesteri. Phytochemistry 2001, 57, 261–265. [CrossRef]
51. Salton, M.R.J.; Kim, K.S. Structure. In Medical Microbiology, 4th ed.; Baron, S., Ed.; University of Texas Medical
Branch at Galveston: Galveston TX, USA, 1996; Chapter 2; Available online: https://www.ncbi.nlm.nih.gov/
books/NBK8477/ (accessed on 8 November 2018).
52. Aboul-Enein, A.M.; El-Ela, F.A.; Shalaby, E.; El-Shemy, H. Potent Anticancer and Antioxidant Activities of
Active Ingredients Separated from Solanum nigrum and Cassia italica Extracts. J. Arid Land Stud. 2014, 24,
145–152.
53. Koduru, S.; Grierson, D.S.; van de Venter, M.; Afolayan, A.J. Anticancer Activity of Steroid Alkaloids Isolated
from Solanum aculeastrum. Pharm. Biol. 2007, 45, 613–618. [CrossRef]
Int. J. Environ. Res. Public Health 2019, 16, 602 12 of 12
54. Chen, Y.T.; Yuan, Q.; Shan, L.T.; Lin, M.A.; Cheng, D.Q.; Li, C.Y. Antitumor activity of bacterial
exopolysaccharides from the endophyte Bacillus amyloliquefaciens sp.isolated from Ophiopogon japonicus.
Oncol. Lett. 2013, 5, 1787–1792. [CrossRef] [PubMed]
55. Cui, J.L.; Guo, S.X.; Xiao, P.G. Antitumor and antimicrobial activities of endophytic fungi from medicinal
parts of Aquilaria sinensis. J. Zhejiang Univ.-Sci. B (Biomed. & Biotechnol.) 2011, 12, 385–392.
56. Lakshmi, P.J.; Selvi, K.V. Anticancer potentials of secondary metabolites from endophytes of
Barringtonia acutangula and its molecular characterization. Int. J. Curr. Microbiol. App. Sci. 2013, 2,
44–45.
57. Wu, Y.; Girmay, S.; da Silva, V.M.; Perry, B.; Hu, X.; Tan, G.T. The Role of Endophytic Fungi in the
Anticancer Activity of Morinda citrifolia Linn. (Noni). Evid.-Based Complement. Alternative Med. 2015,
2015, 393960:1–393960:8.
58. Noch, E.K.; Ramakrishna, R.; Magge, R. Challenges in the Treatment of Glioblastoma: Multisystem
Mechanisms of Therapeutic Resistance. World Neurosurg. 2018, 116, 505–517. [CrossRef] [PubMed]
59. Atkins, R.J.; Styllia, S.S.; Kurganovs, N.; Mangiola, S.; Nowell, C.J.; Ware, T.M.; Corcoran, N.M.; Brown, D.V.;
Kaye, A.H.; Morokoff, A.; et al. Cell quiescence correlates with enhanced glioblastoma cell invasion and
cytotoxic resistance. Exp. Cell Res. 2019, 374, 353–364. [CrossRef] [PubMed]
60. Shanker, M.; Willcutts, D.; Roth, J.A.; Ramesh, R. Drug resistance in lung cancer. Lung Cancer Targets Ther.
2010, 1, 23–36.
61. Bradshaw, A.; Wickremsekera, A.; Tan, S.T.; Peng, L.; Davis, P.F.; Itinteang, T. Cancer stem cell hierarchy in
glioblastoma multiforme. Front. Surg. 2016, 3, 21. [CrossRef]
62. Van Schaijik, B.; Wickremesekera, A.C.; Mantamadiotis, T.; Kaye, A.H.; Tan, S.T.; Stylli, S.S.; Itinteang, T.
Circulating tumor stem cells and glioblastoma: A review. J. Clin. Neurosci. 2018. [CrossRef] [PubMed]
63. Tsvetkova, E.; Goss, G.D. Drug resistance and its significance for treatment decisions in non-small-cell lung
cancer. Curr. Oncol. 2012, 19, S45–S51. [PubMed]
© 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
